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Abstract
Background: This study investigated associations between type 2 diabetes mellitus and non-traditional lipid measures
(total cholesterol (TC)/high-density lipoprotein cholesterol (HDL-C), triglycerides (TG)/HDL-C, and non-HDL-C).
Methods: We conducted a community-based, cross-sectional study of 9 078 participants aged 18 years or
older (4 768 men and 4 310 women) who lived in the Jidong community, Tangshan, China. The adjusted
odds ratios for type 2 diabetes were calculated for every standard deviation change in TC, log-transformed
TG, HDL-C, LDL-C, non-HDL-C, TC/HDL-C, and log-transformed TG/HDL-C using multivariate logistic regression
analysis. Receiver operating characteristic (ROC) curve analysis was used to define the points of maximum
sum of sensitivity and specificity for each lipid measure as a predictor for type 2 diabetes.
Results: Prevalence of type 2 diabetes was 6.29 %. Higher TC, TG, LDL-C, non-HDL-C, TC/HDL-C, and TG/HDL-C, and
lower HDL-C levels were individually associated with type 2 diabetes in multivariate analyses (all P < 0.05). TC/HDL-C
was superior at discriminating between participants with and without type 2 diabetes compared with LDL-C
(comparing ROC: P < 0.001), HDL-C (P < 0.001), TG (P = 0.012), TC (P < 0.001), non-HDL-C (P = 0.001), and TG/HDL-C
(P = 0.03). The cutoff point for TC/HDL-C was 1.30 mmol/L in this population from the Jidong community. Sensitivity
and specificity values for TC/HDL-C were 0.77 and 0.53, respectively.
Conclusions: TC/HDL-C is associated with type 2 diabetes and is superior to LDL-C and HDL-C as a risk marker in this
population.
Keywords: Lipids, Non-HDL cholesterol, type 2 diabetes
Background
The prevalence of type 2 diabetes mellitus is increasing
globally. In the United States, approximately 18.8 million
people were diagnosed with diabetes mellitus in 2010
[1]. The China National Diabetes and Metabolic Disorders
Study reported that there were 92.4 million adults with
diabetes from June 2007 to May 2008 in China [2].
However, there was also about 148.2 million adults with
prediabetes, defined as impaired fasting glucose and/or
impaired glucose tolerance. Identification of risk factors
for the development of type 2 diabetes is urgently needed
to better understand and prevent this public health
epidemic in China.
Previous studies have confirmed that type 2 diabetes
can be prevented by identifying and intervening in the
development of risk factors [3–5]. Studies have shown
that dyslipidemia is one of the known risk factors for
type 2 diabetes [6, 7]. Traditional lipid measures, including
total cholesterol (TC), low-density lipoprotein cholesterol
(LDL-C), and triglycerides (TG), are well documented in
their association with the incidence of type 2 diabetes
[6, 8]. Additionally, evidence indicates that non-high-
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density lipoprotein cholesterol (non-HDL-C) is a super-
ior marker for the development of vascular disease
compared with LDL-C, the traditional lipid measure
[9–12]. Other studies have reported that lipid ratios,
such as TC/HDL-C, have shown a predictive value for
cardiovascular disease [13, 14].
Ley et al. reported that non-HDL-C was associated
with the incidence of type 2 diabetes and was superior
to LDL-C as a risk predictor in 606 diabetes-free partici-
pants [15]. Another prospective study reported that lipid
ratios (TG/HDL-C and TC/HDL-C) were associated with
the incidence of type 2 diabetes among Iranians [16].
There is a lack of data on associations between non-
traditional lipid measures (TC/HDL-C, TG/HDL-C, and
non-HDL-C) and type 2 diabetes in China. The current
study investigated the association between non-traditional
lipid measures with type 2 diabetes and compared their
predictive significance to those of traditional lipid vari-
ables, including TC, LDL-C, and TG, in a population from
the Jidong community, China. We hypothesized that non-
traditional lipid measures (TC/HDL-C, TG/HDL-C, and
non-HDL-C) are associated with type 2 diabetes and are
superior to LDL-C and HDL-C as risk markers in this
population.
Methods
Study design and population
From July 2013 to August 2014, 9 078 residents of the
Jidong community aged 18 years and older were invited
to participate in the study. The community is geographic-
ally located in Tangshan, which is a modern industrial city
located in the central section of the circulating Bohai Sea
Gulf region of China and mainly comprises employees of
Jidong Oilfield Inc. After excluding participants with in-
complete information on type 2 diabetes and lipid meas-
urement data, 8 829 participants were included in the
study. At baseline, physical examinations and surveys were
conducted by trained medical professionals from medical
centers of Jidong Oil Field Inc.
The study was approved by the Ethics Committee of
Jidong Oilfield Inc. Medical Centers, and signed informed
consent was obtained from all participants.
Assessment of potential covariates
A questionnaire was used to obtain data on age, sex,
marital status, personal monthly income, smoking, drink-
ing, physical activity, education level, and history of diseases
(hypertension, type 2 diabetes, stroke, cancer, myocardial
infarction). Questionnaires were administered in person by
research doctors.
Anthropometric measurements, including height, weight,
body mass index (BMI), and blood pressure, were mea-
sured by three trained doctors and nurses. Height was
measured to the nearest 0.1 cm using a tape measure.
Weight was measured to the nearest 0.1 kg using cali-
brated platform scales. BMI was calculated as body weight
(kg) divided by the square of height (m2). Blood pressure
was measured using a mercury sphygmomanometer. Two
readings for systolic blood pressure and diastolic blood
pressure were taken at 5-min intervals with participants
resting in a chair during between measurements. The
average of the two readings was used for analyses. If the
two measurements differed by more than 5 mmHg, an
additional reading was taken, and the average of the three
readings was used [17]. Hypertension was defined based
on a personal history of hypertension, systolic blood pres-
sure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or
currently taking antihypertensive medication prescribed by
a physician [18].
Biochemical index
Blood samples were drawn by trained phlebotomists
from participants after an overnight fast for 8–12 h.
Venous blood samples in tubes containing ethylenedi-
aminetetraacetic acid trisodium salt hydrate were imme-
diately placed on ice after antecubital venipuncture. Fasting
blood glucose (FBG) was measured using the hexokinase/
glucose-6-phosphate dehydrogenase method [19]. TC was
measured using the endpoint test method [20]. HDL-C and
LDL-C levels were measured using the direct test method
[21], and TG was measured using the GPO method [22]
(inter-assay coefficient of variation: <10 %; Mind Bioengin-
eering Co. Ltd, Shanghai, China). All biochemical variables
were measured using an auto analyzer (Olympus AU400;
Olympus, Tokyo, Japan) at the central laboratory at Jidong
Oilfield Hospital. Non-HDL-C levels were determined by
subtracting serum HDL-C levels from TC [11, 15, 16].
Diagnostic criteria for type 2 diabetes
Type 2 diabetes was diagnosed if the participant was
undergoing treatment with insulin or oral hypoglycemic
agents, if FBG levels were ≥7.0 mmol/L, or if the participant
had a personal history of type 2 diabetes [2].
Statistical analysis
Statistical analyses were performed using SAS software,
version 9.4 (SAS Institute, Cary, NC, USA). Data are pre-
sented as mean ± standard deviation (SD) for continuous
variables and as frequencies and percentages for categor-
ical variables. Because TG and TG/HDL-C had a skewed
distribution, they are presented as medians (interquartile
ranges). The Student’s t-test was used for non-paired
samples for comparisons of normally distributed parame-
ters, and the Wilcoxon test was used for comparisons of
non-parametric variables. The chi-squared test was used
for comparisons of categorical variables.
Multiple logistic regression analysis was conducted to
evaluate associations between lipid measures with type 2
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diabetes. The adjusted odds ratio (OR) per 1 SD increase
in the corresponding lipid variable and 95 % confidence
intervals (CI) were calculated. The area under the receiver
operating characteristic (ROC) curve (95 % CI) was used
to compare the ability of different lipid variables in dis-
criminating participants with or without type 2 diabetes.
To determinate appropriate cutoff values of each lipid
measure for predicting type 2 diabetes, ROC curve ana-
lysis was also used to estimate the variable’s sensitivity
and specificity. The cutoff point of each lipid variable
was assessed by the minimum value of √ (1-sensitivity)2 +
(1-specificity)2, which represent the maximum sum of
sensitivity and specificity [23].
All statistical tests were two-sided. A P-value <0.05
was considered statistically significant.
Results
Of the 8 829 participants (4 625 men and 4 204 women;
mean age of 42 years), 555 (6.29 %) were diagnosed with
type 2 diabetes. Compared with those without type 2
diabetes, patients with type 2 diabetes had higher TC/
HDL-C, TG/HDL-C, non-HDL-C, TC, TG, LDL-C,
BMI, and FBG, and were more likely to have hyperten-
sion at baseline (all P < 0.001) (Table 1).
OR of 1 SD change in each lipid marker or index are
listed in Table 2. In the fully adjusted model, there were
positive correlations between TC, TG, non-HDL-C, TG/
HDL-C, and TC/HDL-C with type 2 diabetes, and 1 SD
increase in each of these lipids increased risk for type 2
diabetes by 13 %, 38 %, 23 %, 45 %, and 42 %, respect-
ively (Table 2). The positive correlations between each
lipid marker with type 2 diabetes persisted when partici-
pants with hypertension were further excluded in the
sensitivity analyses (Table 2).
Table 3 shows the ROC curve and cutoff points for
lipid measures for the prediction of type 2 diabetes with
their corresponding specificity and sensitivity. Cutoff
points for LDL-C, HDL-C, TG, non-HDL-C, TG/HDL-C,
and TC/HDL-C to predict type 2 diabetes were 1.20, 1.18,
1.23, 1.19, 1.24, and 1.30 mmol/L, respectively.
Comparing ROC curves, TC/HDL-C was a more su-
perior discriminant of participants with and without type
2 diabetes than LDL-C (comparing ROC: P < 0.001),
HDL-C (P < 0.001), TG (P = 0.012), TC (P < 0.001), non-
HDL-C (P = 0.001), and TG/HDL-C (P = 0.03).
The significant positive association between each lipid
marker with type 2 diabetes and the trend seen by com-
paring ROC curves for each lipid marker persisted when
participants with hypertension were further excluded in
the sensitivity analyses (Table 3).
Discussion
In this study, TC/HDL-C was found to be associated
with type 2 diabetes, and was a superior marker or index
for discriminating individuals with and without type 2
diabetes compared with LDL-C, HDL-C, or non-HDL-C
in this population from the Jidong community, China.
Although the association between lipid ratios and inci-
dent vascular disease is well documented [10, 13, 14],
data on associations between TC/HDL-C and TG/HDL-C
with type 2 diabetes are limited. Our study suggests that
higher TC/HDL-C or TG/HDL-C is associated with an
increased risk for type 2 diabetes. TC/HDL-C is an indir-
ect estimate of LDL-C particle number, and the LDL-C
particle number is closely related to atherosclerosis and
Table 1 Baseline characteristics of study participants with and
without type 2 diabetes
Characteristics Diabetes Without diabetes P-value
No. 555 8274
Age (years) 54.40 ± 10.98 41.12 ± 12.73 <0.001
Gender, male, n (%) 354(63.78) 4271(51.62) <0.001







Middle school 335(60.36) 2790(33.72)
College/University 170(30.63) 5217(63.05)
Drinking (yes) 196(35.31) 2743(33.15) <0.001
Smoking (yes) 177(31.95) 2121(25.64) <0.001
Physical activity (active) 351(63.24) 4216(50.95) <0.001




142.02 ± 21.19 125.26 ± 17.98 <0.001
Diastolic blood pressure
(mmHg)
87.61 ± 13.53 80.44 ± 12.85 <0.001
Hypertension, yes 379(68.29) 2318(28.02) <0.001
Lipid profile
LDL-C (mmol/L) 2.75 ± 0.65 2.45 ± 0.60 <0.001
HDL-C (mmol/L) 1.10 ± 0.25 1.20 ± 0.27 <0.001
TG (mmol/L)a 1.71(1.16–2.63) 1.21(0.84–1.84) <0.001
TC (mmol/L) 4.81 ± 0.96 4.42 ± 0.87 <0.001
Non-HDL-C (mmol/L) 3.70 ± 0.90 3.22 ± 0.85 <0.001
TG/HDL-Ca 1.58(1.00–2.66) 1.04(0.65–1.72) <0.001
TC/HDL-C 4.50 ± 1.13 3.83 ± 1.02 <0.001
Fasting glucose (mmol/L) 8.24 ± 2.48 5.04 ± 0.50 <0.001
BMI body mass index, HDL-C high-density lipoprotein cholesterol, LDL-C low-density
lipoprotein cholesterol, Non-HDL-C non-high-density lipoprotein cholesterol, TC total
cholesterol, TG triglycerides
aMedians (25th–75th percentile)
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cardiometabolic risk compared with LDL-C [9]. Similar to
the findings of the current study, a previous prospective
study reported that adjusted TC/HDL-C is associated with
the incidence of type 2 diabetes among Iranian men (OR:
1.44; 95 % CI: 1.22–1.69) and women (OR: 1.37; 95 % CI:
1.21–1.55) [16], and adjusted TG/HDL-C is associated
with the incidence of type 2 diabetes among Iranian men
(OR: 1.44; 95 % CI: 1.25–1.65) and women (OR: 1.78;
95 % CI: 1.53–2.06) [16]. Ley et al. also reported that TC/
HDL-C is associated with the incidence of type 2 diabetes
in non-Aboriginal populations [15]. Kimm et al. reported
that lipid ratios, including TC/HDL-C and TG/HDL-C,
are associated with insulin resistance and might be used
as integrated lipid values [24].
In the current study, areas under ROC curves for each
lipid measure (LDL-C, HDL-C, TG, TC, non-HDL-C,
TG/HDL-C, and TC/HDL-C) were 0.632, 0.603, 0.659,
0.621, 0.656, 0.666, and 0.684, respectively, suggesting
that TC/HDL-C might be a superior predictor of type 2
diabetes compared with LDL-C. As mentioned, Hadaegh
et al. [16] also reported lipid ratios were superior in their
association with type 2 diabetes in Iranian men and
women. However, in another prospective study carried
out by Ley et al. [15], the researchers reported that non-
HDL-C was associated with the incidence of type 2
diabetes and was superior to LDL-C as a risk predictor
in that population. The differences may arise from dif-
ferences in ethnicities of the studied populations. Par-
ticipants in the current study are mainly Han-ethnic
Chinese (97.2 %), probably having different diverse so-
cioeconomic factors and lifestyles compared with other
ethnic populations.
In the data analysis in the current study, ROC analysis
was used to calculate the cutoff points of lipid variables
based equally on weighted sensitivity and specificity, hence
these cutoff points have low sensitivity for predicting dia-
betes in clinical practice. Additionally, these points may
not be the optimal cutoffs in clinical settings because
Table 2 Logistic regression analysis of associations between lipids and type 2 diabetes
Odds ratio (OR) (95 % CI) Sensitivity analysesd
SD Model 1a Model 2b Model 3c Odds ratio (95 % CI)
LDL-C (mmol/L) 0.6086 1.57(1.45–1.70) 1.21(1.10–1.33) 1.14(1.04–1.25) 1.21(1.03–1.43)
HDL-C (mmol/L) 0.2696 0.68(0.61–0.75) 0.68(0.61–0.76) 0.74(0.66–0.83) 0.66(0.54–0.81)
TG (mmol/L)e 0.5976 1.68(1.56–1.82) 1.49(1.36–1.63) 1.38(1.25–1.53) 1.55(1.31–1.84)
TC (mmol/L) 0.8792 1.50(1.39–1.63) 1.18(1.08–1.29) 1.13(1.03–1.24) 1.18(1.00–1.38)
Non-HDL-C (mmol/L) 0.8595 1.66(1.54–1.80) 1.31(1.20–1.44) 1.23(1.12–1.35) 1.32(1.12–1.55)
TG/HDL-Cf 0.7256 1.71(1.58–1.85) 1.56(1.42–1.72) 1.45(1.31–1.60) 1.64(1.38–1.96)
TC/HDL-C 1.0356 1.70(1.57–1.83) 1.52(1.39–1.66) 1.42(1.30–1.57) 1.59(1.37–1.85)
Odds ratio (OR) (95 % CI) per 1 SD change. HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, Non-HDL-C non-high-density
lipoprotein cholesterol, SD standard deviation, TC total cholesterol, TG triglycerides
aUnadjusted
bAdjusted for age, sex, marital status, personal monthly income level, education level, smoking, drinking, physical activity, and hypertension
cAdditionally adjusted for BMI
dAdjusted for model 3 and further excluded individuals with hypertension
eLog-transformed TG used
fLog-transformed TG/HDL-C used
Table 3 ROC curve for predicting diabetes and cutoff points for maximum sum of sensitivity and specificity
ROC (95 % CI) Cut point Sensitivity (%) Specificity (%) ROC (95 % CI)a
LDL-C (mmol/L) 0.632 (0.608–0.655) 1.20 0.60 0.61 0.648 (0.608–0.687)
HDL-C (mmol/L) 0.603 (0.579–0.627) 1.18 0.65 0.53 0.632 (0.589–0.674)
TG (mmol/L) 0.659 (0.637–0.683) 1.23 0.58 0.65 0.669 (0.629–0.708)
TC (mmol/L) 0.621 (0.597–0.646) 1.19 0.53 0.66 0.626 (0.585–0.668)
Non-HDL-C (mmol/L) 0.656 (0.634–0.679) 1.23 0.61 0.62 0.673 (0.635–0.712)
TG/HDL-C 0.666 (0.643–0.688) 1.24 0.87 0.37 0.682 (0.644–0.720)
TC/HDL-C 0.684 (0.663–0.705) 1.30 0.77 0.53 0.717 (0.680–0.754)
HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, Non-HDL-C non-high-density lipoprotein cholesterol, TC total cholesterol,
TG, triglycerides. Cut points are presented as mmol/L
TC/HDL-C was a better predictor than LDL-C (comparing ROC: P < 0.001), HDL-C (P < 0.001), TG (P = 0.012), TC (P < 0.001), non-HDL-C (P = 0.001), and
TG/HDL-C (P = 0.03)
aFurther excluded individuals with hypertension
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sensitivity vs. specificity should be weighed against many
other factors, such as the seriousness of the illness, how
invasive or feasible it might be, the test used for first
evaluation, and finally how often the test should be
performed [25].
Several limitations should be considered when inter-
preting the results of the current study. First, type 2
diabetes was diagnosed based on a single FBG level
without an oral glucose tolerance test [15] for further
diagnosis. It is therefore possible that patients with type
2 diabetes might have been missed. This would result in
the impact between increased lipid ratios and type 2 dia-
betes being underestimated. However, the same method
for diagnosing type 2 diabetes with a single FBG meas-
urement was used in previous epidemiological studies
(the Framingham Heart Study [26] and the Kailuan study
[19]). Second, inclusion of individuals who had a higher
proportion of hypertension at baseline might influence the
results of the association. However, with sensitivity ana-
lyses, these people were further excluded, and the signifi-
cant positive associations between type 2 diabetes with
each lipid marker and the trend seen when comparing the
C-statistics for each lipid marker were consistent. Third,
all participants are from the Jidong community, and have
a relatively higher income status and have attained higher
education compared with the general Chinese population.
Therefore, generalizations about the entire Chinese popu-
lation cannot be drawn from the results. Finally, this study
was a cross-sectional study, which limits the ability to
conclude a cause-effect association between lipid ratios
and type 2 diabetes.
Conclusions
The results of the current study suggest that TC/HDL-C
strongly correlates with type 2 diabetes, and together with
established independent lipid measures such as HDL-C
and LDL-C in this population. The predicative significance
of TC/HDL-C for type 2 diabetes is better than LDL-C or
HDL-C in this Chinese population. The results support
using TC/HDL-C information, which is becoming more
readily available in clinical settings, for communicating
the increased risk for cardiometabolic disease progression
at an early stage, before the onset of diabetes. It is sug-
gested that further studies are required to establish the
utility of TC/HDL-C in more populations before it can be
incorporated into clinical decision making for the preven-
tion of type 2 diabetes.
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